LOS ANGELES CAPITAL MANAGEMENT LLC - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 139 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$2,529,802
+12.0%
145,642
-9.2%
0.01%
+22.2%
Q2 2023$2,258,348
+84.7%
160,394
+41.1%
0.01%
+80.0%
Q1 2023$1,222,842
-30.6%
113,647
-3.4%
0.01%
-44.4%
Q4 2022$1,763,236
+11.7%
117,706
-4.3%
0.01%
+12.5%
Q3 2022$1,579,000
+148.7%
122,990
+87.5%
0.01%
+166.7%
Q2 2022$635,000
-2.2%
65,582
+0.4%
0.00%0.0%
Q1 2022$649,000
-8.1%
65,322
+8.9%
0.00%0.0%
Q4 2021$706,000
+93.4%
59,970
+86.9%
0.00%
+50.0%
Q3 2021$365,000
-42.8%
32,084
-29.9%
0.00%
-33.3%
Q2 2021$638,000
+54.5%
45,776
+105.2%
0.00%
+50.0%
Q1 2021$413,000
-16.9%
22,313
-20.7%
0.00%0.0%
Q4 2020$497,000
+22.4%
28,123
+6.0%
0.00%0.0%
Q3 2020$406,000
-28.8%
26,532
+18.7%
0.00%
-33.3%
Q2 2020$570,000
+105.0%
22,353
+24.6%
0.00%
+50.0%
Q1 2020$278,000
+93.1%
17,940
+37.6%
0.00%
+100.0%
Q4 2019$144,00013,0400.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 2,474,561$42,983,1255.17%
Rubric Capital Management LP 3,077,449$53,455,2892.00%
Parkman Healthcare Partners LLC 509,810$8,855,4001.62%
TANG CAPITAL MANAGEMENT LLC 600,000$10,422,0001.47%
AlphaCentric Advisors LLC 110,000$1,910,7001.08%
Lion Point Capital, LP 130,691$2,270,1031.01%
RICE HALL JAMES & ASSOCIATES, LLC 650,366$11,296,8570.72%
ESSEX INVESTMENT MANAGEMENT CO LLC 185,853$3,228,2670.53%
ADVISORY RESEARCH INC 204,098$3,545,1820.49%
Jackson Creek Investment Advisors LLC 65,607$1,1400.48%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders